- ASSISTANT PROFESSOR | Medicine, Liver Diseases
- Liver Medicine
- Chinese (Cantonese)
- Chinese (Mandarin)
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Queens
American Board of Internal Medicine
- Colon Polypectomy
- Colon Polyps
- Endoscopic Band Ligation
- Esophageal Variceal Injection
- Esophageal Varices
- HIV Coinfection In Viral Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Liver Biopsy
- Toxic Hepatitis
- Upper GI Endoscopy
- Upper GI Endoscopy, Diagnostic
Hepatitis C Virus
MD, SUNY Downstate Medical Center - College of Medicine
Gastroenterology, North Shore LIJ Health Systems
Internal Medicine, UMDNJ Robert Wood Johnson University Hospital
MD, SUNY Downstate
Transplant Hepatology, Icahn School of Medicine at Mount Sinai
Residency, Internal Medicine
UMDNJ-Robert Wood Johnson
St. Vincent's Hospital [CLOSED]
Long Island Jewish Medical Center
Fellowship, Liver Transplant
Mount Sinai Hospital
Chinese (Cantonese), Chinese (Mandarin), English, Spanish
A Single Arm, Open-label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment Naïve Adults with Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
The purpose of this study is to evaluate 8 weeks of glecaprevir/pibrentasvir in treatment naive male and female subjects aged 18 years or older with chronic HCV GT 1, 2, 4, 5, or 6 infection, with compensated cirrhosis to determine if the study drugs are safe and able to reduce t...
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Law did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.